
AML Therapeutics Market to Reach $10.1 Billion by 2036 Driven by Precision Oncology and Targeted Therapies
The global acute myeloid leukemia therapeutics market is projected to grow from $3.8 billion in 2025 to $10.1 billion by 2036, driven by the shift toward precision oncology, targeted therapies, and personalized medicine.
Read full story






















